Mao Kai, Klionsky Daniel J
a Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology , University of Michigan , Ann Arbor , MI , USA.
b Present address: Department of Molecular Biology, Massachusetts General Hospital, and Department of Genetics , Harvard Medical School , Boston , MA , USA.
Autophagy. 2017 Feb;13(2):223-224. doi: 10.1080/15548627.2016.1267075.
In eukaryotes, xenophagy is defined as a type of selective macroautophagy/autophagy that is used for eliminating invading pathogens. In contrast to other types of selective autophagy, such as mitophagy, pexophagy and ribophagy, xenophagy is used by eukaryotes for targeting microbes-hence the prefix "xeno" meaning "other" or "foreign"-that have infected a host cell, leading to their lysosomal degradation. This unique characteristic links xenophagy to antibacterial and antiviral defenses, as well as the immune response. Furthermore, recent studies suggest a complicated role of xenophagy in cancer, through either suppressing tumorigenesis or promoting survival of established tumors. In this issue, Sui et al. summarize previous and current studies of xenophagy and consider them in the context of anticancer treatment.
在真核生物中,异噬作用被定义为一种选择性巨自噬/自噬,用于清除入侵的病原体。与其他类型的选择性自噬(如线粒体自噬、过氧化物酶体自噬和核糖体自噬)不同,真核生物利用异噬作用来靶向已感染宿主细胞的微生物——因此前缀“xeno”意为“其他的”或“外来的”——从而导致它们被溶酶体降解。这一独特特性将异噬作用与抗菌和抗病毒防御以及免疫反应联系起来。此外,最近的研究表明,异噬作用在癌症中发挥着复杂的作用,既可以抑制肿瘤发生,也可以促进已形成肿瘤的存活。在本期中,隋等人总结了以往和当前关于异噬作用的研究,并在抗癌治疗的背景下对其进行了探讨。